Inventor · disambiguated record
Mingbao Zhang
Also filed as: ZHANG MINGBAO
31 granted patents·16 pending applications·301 citations·filing 1998–2025
97Inventor score
Files withMARINUS PHARMACEUTICALS10MARINUS PHARMACEUTICALS INC9INSIGNIS THERAPEUTICS INC6BAYER PHARMACEUTICALS CORP5ALLIED SIGNAL INC4
Top patents by PatentIndex Score
47 records- 0197US8618087B2Solid ganaxolone formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2012·Granted Dec 31, 2013·35 cites·54 claims
- 0297US7858609B2Solid ganaxolone formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2006·Granted Dec 28, 2010·46 cites·62 claims
- 0396US9056116B2Liquid ganaxolone formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2012·Granted Jun 16, 2015·26 cites·60 claims
- 0496US8022054B2Liquid ganaxolone formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2006·Granted Sep 20, 2011·30 cites·51 claims
- 0595US9029355B2Solid ganaxolone compositions and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2013·Granted May 12, 2015·22 cites·47 claims
- 0695US8367651B2Solid ganaxolone formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2011·Granted Feb 5, 2013·22 cites·51 claims
- 0794US8318714B2Liquid ganaxolone formulations and methods for the making and use thereofSHAW KENNETH·Filed 2011·Granted Nov 27, 2012·22 cites·55 claims
- 0892US9452176B2Solid ganaxolone compositions and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2015·Granted Sep 27, 2016·8 cites·30 claims
- 0990US10780099B2Injectable neurosteroid formulations containing nanoparticlesMARINUS PHARMACEUTICALS INC·Filed 2016·Granted Sep 22, 2020·3 cites·22 claims
- 1088US11071740B2Method of treatment using nanoparticulate ganaxolone formulationsMARINUS PHARMACEUTICALS INC·Filed 2018·Granted Jul 27, 2021·1 cites·28 claims
- 1188US8455002B2Stable corticosteroid nanoparticulate formulations and methods for the making and use thereofSHAW KENNETH·Filed 2010·Granted Jun 4, 2013·11 cites·28 claims
- 1286US9017728B2Stable corticosteroid nanoparticulate formulations and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2013·Granted Apr 28, 2015·7 cites·29 claims
- 1386US7091228B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Aug 15, 2006·18 cites·20 claims
- 1486US2025325562A1Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure DisordersMARINUS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1583US7358386B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Apr 15, 2008·5 cites·2 claims
- 1682US6828335B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2002·Granted Dec 7, 2004·15 cites·102 claims
- 1782US2024016817A1Intravenous Ganaxolone Formulations and Methods of Use in Treating Status Epilepticus and Other Seizure DisordersMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1880US2023293549A1Intravenous ganaxolone formulations and methods of use in treating status epilepticus and other seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1979US8362028B2Pseudobase benzo[c]phenanthridines with improved efficacy, stability and safetyUNIV YALE·Filed 2009·Granted Jan 29, 2013·1 cites·1 claims
- 2079US7968576B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesitySMITH ROGER A·Filed 2008·Granted Jun 28, 2011·3 cites·15 claims
- 2177US2025000821A1Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2276US7112597B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Sep 26, 2006·7 cites·73 claims
- 2376US2023181600A1Injectable neurosteroid formulations containing nanoparticlesMARINUS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2474US7423156B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER PHARMACEUTICALS CORP·Filed 2006·Granted Sep 9, 2008·1 cites·20 claims
- 2573US6054622AAromatic hydroxythiol synthesis using diazonium saltsALLIED SIGNAL INC·Filed 1998·Granted Apr 25, 2000·13 cites·14 claims
- 2668US11213496B2Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2018·Granted Jan 4, 2022·0 cites·27 claims
- 2767US8541618B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Sep 24, 2013·1 cites·44 claims
- 2867US2022193010A1Methods of using dipivefrinINSIGNIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2966US8013166B2Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER HEALTHCARE LLC·Filed 2008·Granted Sep 6, 2011·0 cites·18 claims
- 3065US2009197795A1Preparation and use of aryl alkyl acid derivatives for the treatment of obesityBAYER HEALTHCARE LLC·Filed 2008·Application pending·0 cites
- 3165US2021128583A1Injectable neurosteroid formulations containing nanoparticlesMARINUS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 3264US2017202855A1Solid ganaxolone compositions and methods for the making and use thereofMARINUS PHARMACEUTICALS·Filed 2016·Application pending·0 cites
- 3362US11213484B2Dipivefrin orally disintegrating tablet formulationsINSIGNIS THERAPEUTICS INC·Filed 2020·Granted Jan 4, 2022·0 cites·21 claims
- 3462US2022071898A1Dipivefrin orally disintegrating tablet formulationsINSIGNIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3560US2009004262A1Nanoparticulate formulations and methods for the making and use therofMARINUS PHARMACEUTICALS·Filed 2007·Application pending·0 cites
- 3659US2011065129A1Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2009·Application pending·0 cites
- 3759US2009047687A1Indane Acetic Acid Derivatives and Their Use as Pharmaceutical Agents, Intermediates, and Method of PreparationLOWE DEREK B·Filed 2008·Application pending·0 cites
- 3857US7531550B2Pseudobase benzo[c]phenanthridines with improved efficacy, stability, and safetyUNIV YALE·Filed 2007·Granted May 12, 2009·0 cites·27 claims
- 3954US2025387363A1Liquid epinephrine prodrug formulations and liquid epinephrine formulationsINSIGNIS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4053US2016228454A1Intravenous ganaxolone formulations and methods of use in treating status epilepticus and other seizure disordersMARINUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4152US8552203B2Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparationLOWE DEREK B·Filed 2011·Granted Oct 8, 2013·0 cites·11 claims
- 4248US2018296487A1Sustained release injectable neurosteroid formulationsMARINUS PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 4347US11770200B2On-board synchronization device and smart machineBEIJING TUSEN ZHITU TECH CO LTD·Filed 2020·Granted Sep 26, 2023·0 cites·20 claims
- 4445US6476248B1Hydroxythiol grignard reaction synthesisHONEYWELL INT INC·Filed 2000·Granted Nov 5, 2002·0 cites·3 claims
- 4542US6340773B1Preparation of halogenated primary aminesALLIED SIGNAL INC·Filed 1999·Granted Jan 22, 2002·2 cites·26 claims
- 4641US6303822B1Aromatic hydroxythiol synthesis using diazonium saltsALLIED SIGNAL INC·Filed 2000·Granted Oct 16, 2001·0 cites·5 claims
- 4736US6054623AHydroxythiol grignard reaction synthesisALLIED SIGNAL INC·Filed 1998·Granted Apr 25, 2000·2 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Mingbao Zhang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →